Trastuzumab Description and Brand Names

Trastuzumab Description and Brand Names trastuzumab For treating certain types of breast, stomach or esophagus cancers, and othersTrastuzumab is available as a biosimilar medication See our biosimilar pamphlet trastuzumab Cardiotoxicity Trastuzumab is a monoclonal antibody tyrosine kinase inhibitor that targets the HER2 receptor often over overexpressed or overactive in breast

trastuzumab For women with HER2-positive metastatic breast cancer, trastuzumab may be given on its own or with other treatments Treatment with trastuzumab

trastuzumab Trastuzumab was developed by Genentech Inc as a recombinant humanized monoclonal antibody directed against the แนวทางการกากับการใช้ยา Trastuzumab ข้อบ่งใช้มะเร็งเต้านมระยะเริ่มต้น ผู้ป่วยสิทธิประกันสุขภาพถ้วนหน้า Page 2 Page 3 Page 4